CD24 and neoplasm: In our cohort, flow cytometry analysis revealed a higher number of leukocytes expressing a significantly higher percentage of CD24+/CD11b− PBLs among HN cancer patients peripheral blood samples and in immunohistochemistry of tumor tissue compared with normal controls.